F. Bertoni

The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.

M. Buglione, S. Magrini, E. Mazzeo, 2014, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

R. Orecchia, A. Paccagnella, C. Casanova, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma.

A. López-Guillermo, F. Cavalli, A. Elia, 2021, Blood.

The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma

S. Pileri, D. Rossi, G. Gaidano, 2014, Leukemia.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor.

M. Wymann, F. Beaufils, C. Tarantelli, 2022, European journal of medicinal chemistry.

GPCR Inhibition in Treating Lymphoma

F. Bertoni, M. Barreca, V. Spanò, 2022, ACS medicinal chemistry letters.

MiR‐22, a serum predictor of poor outcome and therapy response in diffuse large B‐cell lymphoma patients

M. Marino, A. Sacconi, M. Rizzo, 2021, British journal of haematology.

Highly Selective Allosteric Modulator of the Phosphoinositide 3‐Kinase Delta (PI3Kδ) Roginolisib In Patients With Refractory/Relapsed Follicular Lymphoma

C. Tarantelli, F. Bertoni, T. Hammett, 2023, Hematological Oncology.

The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.

M. Buglione, S. Magrini, E. Mazzeo, 2014, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.